Interleukin-6-type cytokines in diagnostics and therapeutics: Roundtable discussion.

被引：0
|
作者：
Abdul-Ahad, A
Baumann, H
Elias, JA
Fey, G
Gordon, MS
Heinrich, PC
Horn, F
Koj, A
Kopf, M
Poli, V
Revel, M
Sehgal, PB
Wallace, PM
Weber, JS
机构：
来源：
INTERLEUKIN-6 TYPE CYTOKINES | 1995年 / 762卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：375 / 387
页数：13
相关论文
共 43 条
  • [31] Circulating interleukin-6 (IL-6) type cytokines and soluble interleukin-6 receptor (sIL-6R) in patients with multiple myeloma (MM).
    Wierzbowska, A
    Urbanska-Rys, H
    Robak, T
    [J]. BLOOD, 1998, 92 (10) : 272B - 272B
  • [32] The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells
    Stobbe-Maicherski, Natalie
    Wolff, Sandra
    Wolff, Christian
    Abel, Josef
    Sydlik, Ulrich
    Frauenstein, Katrin
    Haarmann-Stemmann, Thomas
    [J]. FEBS JOURNAL, 2013, 280 (24) : 6681 - 6690
  • [33] INTERLEUKIN (IL)-6-TYPE CYTOKINES IN NEUROPROTECTION: IL-6 AND OSM PROTECT NEURONS AGAINST EXCITOTOXICITY DIFFERENTLY FROM LIF
    Moidunny, S.
    Boddeke, E.
    Limatola, C.
    Enrique, E.
    Biber, K.
    [J]. GLIA, 2009, 57 (13) : S32 - S32
  • [34] CYTOKINES AND HEPATOCELLULAR CARCINOMA: POTENTIAL PROGRESSION MARKERS AND CELL TYPE-SPECIFIC MODULATORS OF THE MIRNOME (EG INTERLEUKIN-6 AND OTHER JAK/STAT ACTIVATING CYTOKINES)
    Kirchmeyer, M.
    Servais, F. A.
    Hamdorf, M.
    Haan, C.
    Nazarov, P.
    Vallar, L.
    Casper, M.
    Glanemann, M.
    Arslanow, A.
    Rubie, C.
    Lammert, F.
    Kreis, S.
    Behrmann, I.
    [J]. CYTOKINE, 2016, 87 : 71 - 72
  • [35] Soluble mannose 6-phosphate/insulin-Like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II
    Duplomb, L
    Chaigne-Delalande, B
    Vusio, P
    Raher, S
    Jacques, Y
    Godard, A
    Blanchard, F
    [J]. ENDOCRINOLOGY, 2003, 144 (12) : 5381 - 5389
  • [36] Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 receptor (sIL-6R) in patients with multiple myeloma
    Urbanska-Rys, H
    Wierzbowska, A
    Stepien, H
    Robak, T
    [J]. EUROPEAN CYTOKINE NETWORK, 2000, 11 (03) : 443 - 451
  • [37] Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements
    Lai, CF
    Ripperger, J
    Morella, KK
    Jurlander, J
    Hawley, TS
    Carson, WE
    Kordula, T
    Caliguri, MA
    Hawley, RG
    Fey, GH
    Baumann, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 13968 - 13975
  • [38] Signalling of interleukin-6 type cytokines via gp130, leukemia inhibitory factor (LIF) receptor and oncostatin M receptor
    Behrmann, I
    Hermanns, HM
    Haan, C
    Kortylewski, M
    Radtke, S
    Greiser, J
    Heinrich, PC
    [J]. EUROPEAN CYTOKINE NETWORK, 2000, 11 (03) : 491 - 492
  • [39] Mechanism of hepatocellular dysfunction during early sepsis - Key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6 - Discussion
    Hechtman, HB
    Friedmann, P
    Wang
    [J]. ARCHIVES OF SURGERY, 1997, 132 (04) : 369 - 370
  • [40] Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes
    Ladefoged, Mette
    Buschard, Karsten
    Hansen, Ann Maria Kruse
    [J]. APMIS, 2013, 121 (06) : 531 - 538
12345